Related Experiment Videos
Biological imaging in radiation oncology
Anca-Ligia Grosu1, Nicole Wiedenmann, Michael Molls
1Department of Radiation Oncology, Klinik und Poliklinik für Strahlentherapie und Radiologische Onkologie, Klinikum rechts der Isar, Technical University of Munich, Germany. anca-ligia.grosu@lrz.tum.de
Zeitschrift Fur Medizinische Physik
|September 21, 2005
Summary
Integrating biological imaging like PET and SPECT enhances radiation therapy planning and monitoring. This approach allows for more precise tumor targeting and better assessment of treatment response compared to traditional methods.
Area of Science:
- Oncology
- Medical Imaging
- Radiation Therapy
Background:
- Current radiation therapy planning relies heavily on anatomical imaging (CT, MRI).
- Biological imaging offers insights into tumor heterogeneity and biological characteristics.
- There's a growing need to integrate advanced imaging for personalized cancer treatment.
Purpose of the Study:
- To evaluate the value of biological imaging in radiation treatment planning and monitoring.
- To compare the efficacy of biological imaging with conventional methods in defining tumor volumes.
- To explore the role of biological imaging in assessing therapy response.
Main Methods:
- Review of studies integrating Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT), and Magnetic Resonance Spectroscopy (MRS) in radiation therapy.
- Image fusion techniques combining CT/MRI with PET/SPECT for improved Gross Tumor Volume (GTV) and Planning Target Volume (PTV) delineation.
- Analysis of studies utilizing functional imaging for hypoxia, proliferation, and angiogenesis.
Main Results:
- Image fusion of CT/MRI with amino acid PET/SPECT improves GTV/PTV delineation in brain tumors.
- FDG-PET shows comparable results for various cancers including lung, head and neck, and cervical carcinomas.
- Biological imaging identifies aggressive tumor areas for targeted therapy (dose painting) and shows higher sensitivity/specificity for therapy response assessment than anatomical imaging.
Conclusions:
- Biological imaging significantly enhances radiation therapy planning by enabling precise tumor delineation and identification of aggressive subvolumes.
- Functional imaging, particularly FDG-PET, demonstrates superior accuracy in evaluating therapy response compared to CT and MRI.
- Further clinical and experimental studies are needed to fully establish the impact of biological imaging in radiation oncology.